JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on December 17, 2004; DOI: 10.1124/jpet.104.078592


0022-3565/05/3131-250-259$20.00
JPET 313:250-259, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.078592v1
313/1/250    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tertyshnikova, S.
Right arrow Articles by Lodge, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tertyshnikova, S.
Right arrow Articles by Lodge, N. J.

CELLULAR AND MOLECULAR

BL-1249 [(5,6,7,8-Tetrahydro-naphthalen-1-yl)-[2-(1H-tetrazol-5-yl)-phenyl]-amine]: A Putative Potassium Channel Opener with Bladder-Relaxant Properties

Svetlana Tertyshnikova, Ronald J. Knox, Mary Jane Plym, George Thalody, Corinne Griffin, Torben Neelands1, David G. Harden, Laura Signor, David Weaver2, Robert A. Myers, and Nicholas J. Lodge

Neuroscience Drug Discovery (S.T., M.J.P., G.T., C.G., T.N., L.S., R.A.M., N.J.L.) and Lead Discovery and Profiling (R.J.K., D.G.H., D.W.), Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, Connecticut

BL-1249 [(5,6,7,8-tetrahydro-naphthalen-1-yl)-[2-(1H-tetrazol-5-yl)-phenyl]-amine] produced a concentration-dependent membrane hyperpolarization of cultured human bladder myocytes, assessed as either a reduction in fluorescence of the voltage-sensitive dye bis-(1,2-dibutylbarbituric acid)trimethine oxonol (EC50 = 1.26 ± 0.6 µM) or by direct electrophysiological measurement (EC50 = 1.49 ± 0.08 µM). BL-1249 also produced a membrane hyperpolarization of acutely dissociated rat bladder myocytes. Voltage-clamp studies in human bladder cells revealed that BL-1249 activated an instantaneous, noninactivating current that reversed near EK. The BL-1249-evoked outward K+ current was insensitive to blockade by glyburide, tetraethylammonium, iberiotoxin, 4-aminopyridine, apamin, or Mg2+. However, the current was inhibited by extracellular Ba2+ (10 mM). In in vitro organ bath experiments, BL-1249 produced a concentration-dependent relaxation of 30 mM KCl-induced contractions in rat bladder strips (EC50 = 1.12 ± 0.37 µM), yet had no effect on aortic strips up to the highest concentration tested (10 µM). The bladder relaxation produced by BL-1249 was partially blocked by Ba2+ (1 and 10 mM) but not by apamin, iberiotoxin, 4-aminopyridine, glyburide, or tetraethylammonium. In an anesthetized rat model, BL-1249 (1 mg/kg i.v.) decreased the number of isovolumic contractions, without significantly affecting blood pressure. Thus, BL-1249 behaves as a potassium channel activator that exhibits bladder versus vascular selectivity both in vitro and in vivo. A survey of potassium channels exhibiting sensitivity to extracellular Ba2+ at millimolar concentration revealed that the expression of the K2P2.1 (TREK-1) channel was relatively high in human bladder cells versus human aortic cells, suggesting this channel as a possible candidate target for BL-1249.


Received for publication October 4, 2004
Accepted December 15, 2004.

Address correspondence to: Dr. Svetlana Tertyshnikova, Bristol-Myers Squibb Pharmaceutical Research Institute, Neuroscience Drug Discovery, 5 Research Parkway, Wallingford, CT 06492-7660. E-mail: svetlana.tertyshnikova{at}bms.com




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
E. S. R. Lashinger, M. S. Steiginga, J. P. Hieble, L. A. Leon, S. D. Gardner, R. Nagilla, E. A. Davenport, B. E. Hoffman, N. J. Laping, and X. Su
AMTB, a TRPM8 channel blocker: evidence in rats for activity in overactive bladder and painful bladder syndrome
Am J Physiol Renal Physiol, September 1, 2008; 295(3): F803 - F810.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.